Stem Cell Therapy for Diabetes is being explored from several different angles. One of the primary focuses is stem cells' ability to develop new insulin-producing cells that could replace those lost or damaged by disease. Researchers are also studying ways to protect these cells from the immune system after transplantation. The field has made important progress, but challenges such as safety, cell survival, immune rejection, and long-term effectiveness still need to be addressed. Advancells, India, is a leading manufacturer of clinical-grade stem cells.